Extend your brand profile by curating daily news.

DuLac Farmaceutici Expands U.S. Presence with OneLavi Launch and ECRM Participation

By Burstable Health Team•
Italian pharmaceutical company DuLac Farmaceutici accelerates its U.S. expansion by launching on OneLavi.com and preparing for ECRM meetings with major retailers, leveraging its Amazon success.
DuLac Farmaceutici Expands U.S. Presence with OneLavi Launch and ECRM Participation

Italian pharmaceutical company DuLac Farmaceutici is accelerating its expansion into the U.S. market, announcing that its products are now available through OneLavi.com as it prepares to participate in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, scheduled for September 14-17 in Palm Beach Gardens, Florida. These moves mark significant steps in the company's strategy to broaden its U.S. footprint beyond its established presence on Amazon.

DuLac has already demonstrated strong consumer demand in the U.S. through Amazon, where its Arnica Gel 98% has garnered over 13,000 customer reviews with an average 4.5-star rating, and its Dinaven line has received more than 4,000 reviews with an average 4.6-star rating. The addition of OneLavi provides another e-commerce channel to reach American consumers, while ECRM offers a business-to-business platform to engage with major retail buyers.

Gabriele Bollani, Founder and CEO of DuLac Farmaceutici, emphasized the importance of this phase: "ECRM comes at an important time for DuLac because we are making a major commitment to the U.S. market. Amazon has demonstrated that American consumers are responding to our products, OneLavi gives us another important U.S. channel, and now we are ready to introduce DuLac to major retailers and build the partnerships that can take our expansion to the next level."

At ECRM, DuLac will participate in scheduled meetings with buyers representing health, specialty, food, drug, and mass retail channels. The company will highlight its high-concentration Arnica Gel 98% range, as well as the Dinaven and Diosmin lines, showcasing its Italian pharmaceutical heritage and advanced manufacturing capabilities. The goal is to establish relationships that support a larger and more diversified U.S. retail presence.

DuLac brings over 30 years of pharmaceutical industry expertise and pharmacy-channel experience in Italy to its U.S. expansion. Its product development and manufacturing capabilities include the proprietary Arnica Montana Arricchita™ project, indoor vertical farming, micronized Diosmin MPFF technology, solvent-free Supercritical CO₂ Extraction, and production under internationally recognized GMP and ISO quality frameworks. This combination of innovation and quality forms the foundation for its next stage of growth.

With Amazon already established, OneLavi now live, and ECRM meetings on the horizon, DuLac is transitioning from initial market development to a broader national expansion strategy. The company aims to build a diversified U.S. presence across e-commerce, retail, wholesale, and other distribution channels, introducing more American consumers to its Italian-developed product portfolio.

Burstable Health Team

Burstable Health Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.